The BioPharm International® editors present our most popular technical articles from 2024.
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
BioPharm International® publishes independent, science-based articles and peer-reviewed papers from biopharmaceutical professionals working in the development and manufacturing of biologics. In 2024, BioPharm International®, via print issues, ebooks, and our website, BioPharmInternational.com, published articles on topics ranging from cell and gene therapies, viral clearance, fill/finish, aseptic processing, and more.
The following are our picks for the ‘best of’ technical and peer-reviewed articles published in 2024, in no particular order:
For more peer-reviewed articles, please visit https://www.biopharminternational.com/topic/peer-reviewed-research.
For the latest on drug development, please visit https://www.biopharminternational.com/topic/development.
To read in-depth upstream processing articles, visit https://www.biopharminternational.com/topic/upstream.
A variety of quality-related topics can be found at https://www.biopharminternational.com/topic/quality. And the latest manufacturing technologies are discussed at https://www.biopharminternational.com/topic/manufacturing.
For information on how to submit technical and peer-reviewed articles to BioPharm International®, please view our submission guidelines at https://www.biopharminternational.com/view/editorial-information.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.